logo
Plus   Neg
Share
Email

Novo Nordisk Says FDA Approves To Update Victoza Product Label

Novo Nordisk A/S (NVO) said Friday that the US Food and Drug Administration has approved to update the product label for Victoza to include data showing superior blood sugar control and weight reduction when compared to Januvia.
The update also includes data showing the safety and efficacy of adding basal insulin to Victoza and metformin for the treatment of adults with type 2 diabetes.

The label update is based on data from two large, randomized, open-label studies in adults with type 2 diabetes.

"The data from these studies further demonstrate the strong clinical profile and the value of Victoza in the treatment of type 2 diabetes," said Mads Krogsgaard Thomsen, executive vice president and chief science officer of Novo Nordisk.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Consumer goods giant Procter & Gamble Co. announced Thursday that it has signed an agreement to acquire the Consumer Health business of German drug major Merck KGaA for a purchase price of approximately 3.4 billion euros. P&G expects to close the acquisition of Consumer Health business during the 2018/19 fiscal year, subject to customary closing conditions and regulatory clearances. Alcoa Inc. (AA), the largest producer of aluminum in the US, Wednesday reported a first-quarter profit that trumped Wall Street estimates, driven largely by revenue growth, sending its shares up 5 percent in after-hours trading. New York-based Alcoa's first-quarter profit was $150 million or $0.80... Two Colorado counties and the City of Boulder have filed a lawsuit against Canada-based Suncor Energy Inc. and U.S. giant Exxon Mobil Corp. for the "substantial role" they played in causing and contributing to climate change-related damage to their communities. The communities of Boulder County, San Miguel County and the City of Boulder filed the lawsuit in a U.S. district court.
Follow RTT